Intracellular Historical Income Statement
| ITCI Stock | USD 85.65 0.94 1.09% |
Historical analysis of Intracellular income statement accounts such as Gross Profit of 452.2 M or Research Development of 189.1 M can show how well Intracellular Th performed in making a profits. Evaluating Intracellular income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Intracellular's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Intracellular Th latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intracellular Th is a good buy for the upcoming year.
Intracellular |
About Intracellular Income Statement Analysis
Intracellular Th Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Intracellular shareholders. The income statement also shows Intracellular investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Intracellular Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Intracellular Th generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Intracellular Th. It is also known as Intracellular overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most accounts from Intracellular's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Intracellular Th current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. As of now, Intracellular's Research Development is increasing as compared to previous years. The Intracellular's current Cost Of Revenue is estimated to increase to about 43.9 M, while Operating Income is projected to decrease to (167.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 1.6M | 7.4M | 20.3M | 21.4M | Interest Income | 1.6M | 7.4M | 20.3M | 21.4M |
Intracellular income statement Correlations
Click cells to compare fundamentals
Intracellular Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intracellular income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 6.8M | 4.8M | 2.1M | 7.4M | 8.5M | 8.9M | |
| Total Revenue | 60.6K | 22.5M | 81.7M | 249.1M | 464.4M | 487.6M | |
| Gross Profit | 60.6K | 20.6M | 73.7M | 228.7M | 430.6M | 452.2M | |
| Operating Income | (154.0M) | (231.2M) | (285.7M) | (263.6M) | (159.4M) | (167.4M) | |
| Research Development | 89.1M | 65.8M | 88.8M | 134.7M | 180.1M | 189.1M | |
| Cost Of Revenue | 89.1M | 1.9M | 8.0M | 20.4M | 33.7M | 43.9M | |
| Income Before Tax | (147.7M) | (227.0M) | (284.1M) | (256.3M) | (139.0M) | (146.0M) | |
| Net Income Applicable To Common Shares | (147.7M) | (227.0M) | (284.1M) | (256.3M) | (230.6M) | (219.1M) | |
| Net Income | (147.7M) | (227.0M) | (284.1M) | (256.3M) | (139.7M) | (146.7M) | |
| Depreciation And Amortization | 477.1K | 528.1K | 533.4K | 656K | 528K | 342.7K | |
| Selling General Administrative | 64.9M | 186.4M | 272.6M | 358.8M | 317.7M | 333.5M | |
| Other Operating Expenses | 154.1M | 253.8M | 367.4M | 512.8M | 623.8M | 654.9M | |
| Ebit | (154.0M) | (231.2M) | (285.7M) | (263.6M) | (159.4M) | (167.4M) | |
| Ebitda | (153.5M) | (230.7M) | (285.2M) | (263.0M) | (158.9M) | (166.8M) | |
| Total Operating Expenses | 154.1M | 251.9M | 359.4M | 492.3M | 590.0M | 619.5M | |
| Total Other Income Expense Net | 6.3M | 4.2M | 1.6M | 7.4M | 20.3M | 21.4M | |
| Net Income From Continuing Ops | (147.7M) | (227.0M) | (284.1M) | (256.3M) | (139.7M) | (146.7M) | |
| Non Operating Income Net Other | 6.3M | 4.2M | 1.6M | 7.4M | 8.5M | 8.9M | |
| Interest Income | 6.3M | 4.2M | 1.6M | 7.4M | 20.3M | 21.4M | |
| Net Interest Income | 6.3M | 4.2M | 1.6M | 7.4M | 20.3M | 21.4M | |
| Reconciled Depreciation | 477.1K | 528.1K | 533.4K | 656K | 528K | 519.4K |
Currently Active Assets on Macroaxis
When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share 6.096 | Quarterly Revenue Growth 0.39 | Return On Assets (0.07) | Return On Equity (0.1) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.